在MDA-PCa-2b细胞中的CXCR1表达抑制了ITM2A以抑制瘤生长
Timothy O Adekoya1,2, Nikia Smith1, Parag Kothari1
1Cancer Research Program, Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, NC 27707, USA.
Cancers
|January 8, 2025
概括
前列腺癌 (PCa) 研究显示,CXCR1可以通过增加整体膜蛋白2A (ITM2A) 表达来抑制瘤生长,与CXCR2形成对比.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 化基因及其受体在癌症进展中至关重要.
- 介质素-8 (IL-8/CXCL8) 通过CXCR1和CXCR2促进前列腺癌 (PCa) 血管生成,扩散和转移.
- 此前,CXCR1在PCa进展中的特定作用尚不清楚.
研究的目的:
- 研究CXCR1在前列腺癌发展中的功能作用.
- 为了比较CXCR1和CXCR2在依赖雄激素的PCa细胞系中的作用.
主要方法:
- 在MDA-PCa-2b PCa细胞系中,CXCR1和CXCR2的稳定表达.
- 在体外和体内评估瘤发育,细胞迁移,增殖和蛋白质表达.
- 用RNA测序和西方斑分析来识别分子变化.
主要成果:
- 与对照和CXCR2表达细胞相比,MDA-PCa-2b细胞中的CXCR1表达减少了细胞迁移,AKT激活,PSA表达,增殖和瘤生长.
- CXCR1表达诱导了介质细胞到上皮细胞的过渡,由改变的E-cadherin,N-cadherin和vimentin水平表明.
- 在前列腺腺癌组织中,CXCR1表达显著上调整了整体膜蛋白2A (ITM2A),这是一种瘤抑制剂,在前列腺腺癌组织中下调.
结论:
- 在PCa细胞中表达CXCR1可能会抑制瘤的发展.
- 通过CXCR1对ITM2A的上调似乎是抑制瘤生长的关键机制.
- CXCR1代表前列腺癌的潜在治疗点.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K


